Found: 50
Select item for more details and to access through your institution.
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 3, p. 324, doi. 10.1016/j.clbc.2022.12.006
- By:
- Publication type:
- Article
Gene Delivery in Neuro-Oncology.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 11, p. 1, doi. 10.1007/s11912-017-0628-z
- By:
- Publication type:
- Article
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden.
- Published in:
- Neuro-Oncology Practice, 2014, v. 1, n. 2, p. 47, doi. 10.1093/nop/npu004
- By:
- Publication type:
- Article
Financial burden experienced by patients undergoing treatment for malignant gliomas.
- Published in:
- Neuro-Oncology Practice, 2014, v. 1, n. 2, p. 71, doi. 10.1093/nop/npu002
- By:
- Publication type:
- Article
The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1402651
- By:
- Publication type:
- Article
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Advances in the Diagnosis and Treatment of Leptomeningeal Disease.
- Published in:
- Current Neurology & Neuroscience Reports, 2022, v. 22, n. 7, p. 413, doi. 10.1007/s11910-022-01198-3
- By:
- Publication type:
- Article
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
- Published in:
- BMC Cancer, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s12885-024-12042-x
- By:
- Publication type:
- Article
Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies.
- Published in:
- CNS Drugs, 2022, v. 36, n. 2, p. 167, doi. 10.1007/s40263-021-00894-x
- By:
- Publication type:
- Article
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2133, doi. 10.3390/cancers16112133
- By:
- Publication type:
- Article
Modern Management and Diagnostics in HER2+ Breast Cancer with CNS Metastasis.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2908, doi. 10.3390/cancers15112908
- By:
- Publication type:
- Article
Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 17, doi. 10.3390/cancers14010017
- By:
- Publication type:
- Article
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation results.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01680-0
- By:
- Publication type:
- Article
Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54513-3
- By:
- Publication type:
- Article
A broad perspective on evaluating bias in the neuro-oncology workplace.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 498, doi. 10.1093/neuonc/noaa286
- By:
- Publication type:
- Article
In pursuit of a perpetually burning flame: preventing burnout in neuro-oncology.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 6, p. 750, doi. 10.1093/neuonc/noaa080
- By:
- Publication type:
- Article
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 470, doi. 10.1093/neuonc/noz216
- By:
- Publication type:
- Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
- By:
- Publication type:
- Article
QOLP-25. QUALITY OF LIFE FOLLOWING RE-IRRADIATION FOR RECURRENT HIGH GRADE GLIOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi220, doi. 10.1093/neuonc/noy148.911
- By:
- Publication type:
- Article
ATIM-02. TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB IN RECURRENT OR PROGRESSIVE MENINGIOMA IN A PHASE 2 STUDY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi1, doi. 10.1093/neuonc/noy148.000
- By:
- Publication type:
- Article
ATIM-06. PHASE 2 TRIAL OF SL-701 + BEVACIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED GLIOBLASTOMA (GBM) MEETS PRIMARY ENDPOINT OF OS-12, WITH PRELIMINARY CORRELATION BETWEEN LONG-TERM SURVIVAL AND TARGET-SPECIFIC CD8+ T CELL IMMUNE RESPONSE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi2, doi. 10.1093/neuonc/noy148.003
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 838, doi. 10.1093/neuonc/nox202
- By:
- Publication type:
- Article
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 7, p. 965, doi. 10.1093/neuonc/now257
- By:
- Publication type:
- Article
Optimal Management of Corticosteroids in Patients with Intracranial Malignancies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Primary Central Nervous System Lymphoma.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 2, p. 185, doi. 10.1007/s11864-013-0227-7
- By:
- Publication type:
- Article
CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.745893
- By:
- Publication type:
- Article
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 505, p. 1, doi. 10.1126/scitranslmed.aaw5680
- By:
- Publication type:
- Article
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac123
- By:
- Publication type:
- Article
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac041
- By:
- Publication type:
- Article
Advances in the diagnosis, evaluation, and management of leptomeningeal disease.
- Published in:
- Neuro-Oncology Advances, 2021, v. 3, p. v86, doi. 10.1093/noajnl/vdab108
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00414
- By:
- Publication type:
- Article
Quality of Life of Family Caregivers of Patients With Cancer in Korçe, Albania.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mutant IDH1 and thrombosis in gliomas.
- Published in:
- Acta Neuropathologica, 2016, v. 132, n. 6, p. 917, doi. 10.1007/s00401-016-1620-7
- By:
- Publication type:
- Article
Long-term outcomes of central neurocytoma – an institutional experience.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 1, p. 195, doi. 10.1007/s11060-024-04713-3
- By:
- Publication type:
- Article
Leptomeningeal metastases: the future is now.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 3, p. 443, doi. 10.1007/s11060-021-03924-2
- By:
- Publication type:
- Article
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 155, n. 3, p. 297, doi. 10.1007/s11060-021-03875-8
- By:
- Publication type:
- Article
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 599, doi. 10.1007/s11060-020-03555-z
- By:
- Publication type:
- Article
A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
- Published in:
- 2019
- By:
- Publication type:
- Letter
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 589, doi. 10.1007/s11060-017-2469-x
- By:
- Publication type:
- Article
Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 112, n. 2, p. 247, doi. 10.1007/s11060-013-1055-0
- By:
- Publication type:
- Article
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00587-2
- By:
- Publication type:
- Article
Intracranial Response to Anti‐Programmed Death 1 Therapy in a Patient with Metastatic Non‐Small Cell Lung Cancer with Leptomeningeal Carcinomatosis.
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. e159, doi. 10.1634/theoncologist.2018-0022
- By:
- Publication type:
- Article
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1781, doi. 10.1093/neuonc/noae103
- By:
- Publication type:
- Article
Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. 1687, doi. 10.1093/neuonc/noac142
- By:
- Publication type:
- Article
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.
- Published in:
- Neuro-Oncology, 2022, v. 24, p. 1613, doi. 10.1093/neuonc/noac118
- By:
- Publication type:
- Article
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 584, p. 1, doi. 10.1126/scitranslmed.abb3945
- By:
- Publication type:
- Article
Atypical meningioma: Randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy.
- Published in:
- Journal of Cancer Research & Therapeutics, 2015, v. 11, n. 1, p. 59, doi. 10.4103/0973-1482.148708
- By:
- Publication type:
- Article